Chemoinformatics : concepts, methods, and tools for drug discovery

Molecular Similarity Measures Gerald M. Maggiora and Veerabahu Shanmugasundaram Evaluation of Molecular Similarity and Molecular Diversity Methods Using Biological Activity Data Peter Willett A Web-Based Chemoinformatics System for Drug Discovery Scott D. Bembenek, Brett A. Tounge, Steven J. Coats, and Charles H. Reynolds Application of Chemoinformatics to High Throughput Screening: Practical Considerations Christian N. Parker and Suzanne K. Schreyer Strategies for the Identification and Generation of Informative Compound Sets Michael S. Lajiness and Veerabahu Shanmugasundaram Methods for Applying the Quantitative Structure-Activity Relationship Paradigm Emilio Xavier Esposito, Anton J. Hopfinger, and Jeffry D. Madura 3D-LogP: An Alignment-Free 3D Description of Local Lipophilicity for QSAR Studies Jerome Gomar, Elie Giraud, David Turner, Roger Lahana, and Pierre Alain Carrupt Derivation and Applications of Molecular Descriptors Based on Approximate Surface Area Paul Labute Cell-Based Partitioning Ling Xue, Florence L. Stahura, and Jurgen Bajorath Partitioning in Binary-Transformed Chemical Descriptor Spaces Jeffrey W. Godden and Jurgen Bajorath Comparison of Methods Based on Diversity and Similarity for Molecule Selection and the Analysis of Drug Discovery Data Raymond L. H. Lam and William J. Welch Using Recursive Partitioning Analysis to Evaluate Compound Selection Methods S. Stanley Young and Douglas M. Hawkins Designing Combinatorial Libraries Optimized on Multiple Objectives Valerie J. Gillet Approaches to Target Class Combinatorial Library Design Dora Schnur, Brett R. Beno, Andrew Good, and Andrew Tebben Simulated Annealing: An Effective Stochastic Optimization Approach to Computational Library Design WeifanZheng Genetic Algorithms for Classification of Olfactory Stimulants Barry K. Lavine, Charles E. Davidson, Curt Breneman, and William Kaat How to Describe Chirality and Conformational Flexibility Gordon M. Crippen Novel Scoring Methods in Virtual Ligand Screening Daniel Pick Prediction of Drug-like Molecular Properties: Modeling Cytochrome P450 Interactions Mehran Jalaie, Rieko Arimoto, Eric Gifford, Sabine Schefzick, and Chris L. Waller Index

[1]  Gilles Klopman,et al.  META, 3. A Genetic Algorithm for Metabolic Transform Priorities Optimization , 1997, J. Chem. Inf. Comput. Sci..

[2]  Yi Han,et al.  Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..

[3]  M. Dickins,et al.  Quantitative Structure-Activity Relationships (QSARs) Within Substrates of Human Cytochromes P450 Involved in Drug Metabolism , 2001, Drug metabolism and drug interactions.

[4]  Nenad Trinajstić,et al.  Predicting Inhibition of Microsomal p-Hydroxylation of Aniline by Aliphatic Alcohols: A QSAR Approach Based on the Weighted Path Numbers , 2001 .

[5]  Ferenc Darvas QSAR in Environmental Toxicology. Edited by Klaus L. E. Kaiser. D. Reidel Publishing Company, Dordrecht/Boston/Lancaster, 1986 , 1987 .

[6]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[7]  Alexander D. MacKerell,et al.  An Empirical Potential Energy Function for Phospholipids: Criteria for Parameter Optimization and Applications , 1996 .

[8]  F. Sanz,et al.  Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. , 1993, Molecular pharmacology.

[9]  D. Lewis,et al.  Molecular dimensions of the substrate binding site of cytochrome P-448. , 1986, Biochemical pharmacology.

[10]  James J. P. Stewart,et al.  Application of localized molecular orbitals to the solution of semiempirical self‐consistent field equations , 1996 .

[11]  J. Gasteiger,et al.  FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .

[12]  V. Stella,et al.  Pro-drugs as Novel Drug Delivery Systems , 1975 .

[13]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.

[14]  P. Labute,et al.  Flexible alignment of small molecules. , 2001, Journal of medicinal chemistry.

[15]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[16]  Roberto Todeschini,et al.  MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids , 1997, J. Comput. Aided Mol. Des..

[17]  Michael J. E. Sternberg,et al.  Evidence That Aspartic Acid 301 Is a Critical Substrate-Contact Residue in the Active Site of Cytochrome P450 2D6 (*) , 1995, The Journal of Biological Chemistry.

[18]  Jin-Young Park,et al.  Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations. , 2003, Journal of medicinal chemistry.

[19]  Emili Besalú,et al.  Fast Computation of Cross-Validated Properties in Full Linear Leave-Many-Out Procedures , 2001 .

[20]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[21]  Michael Sjöström,et al.  Chemometrics, present and future success , 1998 .

[22]  C. Waller,et al.  Comparative molecular field analysis of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls. , 1992, Journal of medicinal chemistry.

[23]  C. Hansch,et al.  QSAR of P450 oxidation: on the value of comparing kcat and km with kcat/km. , 1996, Drug metabolism reviews.

[24]  Gilles Klopman,et al.  META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism , 1994, J. Chem. Inf. Comput. Sci..

[25]  A. Hopfinger,et al.  Construction of 3D-QSAR Models Using the 4D-QSAR Analysis Formalism , 1997 .

[26]  Anthony Long,et al.  Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.

[27]  J. Shao Linear Model Selection by Cross-validation , 1993 .

[28]  R. Cramer,et al.  Recent advances in comparative molecular field analysis (CoMFA). , 1989, Progress in clinical and biological research.

[29]  Barry C Jones,et al.  Development of a combined protein and pharmacophore model for cytochrome P450 2C9. , 2002, Journal of medicinal chemistry.

[30]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[31]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[32]  M Karplus,et al.  Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. , 1996, Journal of medicinal chemistry.

[33]  Maurice Dickins,et al.  Quantitative Structure-Activity Relationships (QSARs) Within Series of Inhibitors for Mammalian Cytochromes P450 (CYPs) , 2001, Journal of enzyme inhibition.

[34]  C. McDiarmid SIMULATED ANNEALING AND BOLTZMANN MACHINES A Stochastic Approach to Combinatorial Optimization and Neural Computing , 1991 .

[35]  D F Lewis,et al.  A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing. , 1995, Environmental health perspectives.

[36]  D. Lewis,et al.  A quantitative structure–activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1 , 2003, Journal of biochemical and molecular toxicology.

[37]  W. Richards,et al.  Self-organizing molecular field analysis: a tool for structure-activity studies. , 1999, Journal of medicinal chemistry.

[38]  Tudor I. Oprea,et al.  Virtual Screening in Lead Discovery: A Viewpoint† , 2002, Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry.

[39]  P R Ortiz de Montellano,et al.  The substrate specificity of cytochrome P450cam. , 1998, Bioorganic & medicinal chemistry.

[40]  W. Trager,et al.  Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding. , 1999, Biochemistry.

[41]  Hugo Kubinyi,et al.  Quantitative Structure–Activity Relationships in Drug Design , 2002 .

[42]  D. Lewis,et al.  Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles. , 2000, Toxicology.

[43]  S. Free,et al.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.

[44]  C. Ioannides,et al.  The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis. , 1987, Biochemical pharmacology.

[45]  Paul R. Yarnold,et al.  Reading and Understanding Multivariate Statistics , 1995 .

[46]  Grazyna D. Szklarz,et al.  Secobarbital-mediated Inactivation of Cytochrome P450 2B1 and Its Active Site Mutants , 1996, The Journal of Biological Chemistry.

[47]  R. Clark,et al.  Consensus scoring for ligand/protein interactions. , 2002, Journal of molecular graphics & modelling.

[48]  M C Nicklaus,et al.  Conformational changes of small molecules binding to proteins. , 1995, Bioorganic & medicinal chemistry.

[49]  V. Kulkarni,et al.  Three‐Dimensional Quantitative Structure—Activity Relationship (QSAR) and Receptor Mapping of Cytochrome P‐45014αDM Inhibiting Azole Antifungal Agents. , 1999 .

[50]  H. Hotelling Analysis of a complex of statistical variables into principal components. , 1933 .

[51]  C. Ioannides,et al.  An improved and updated version of the compact procedure for the evaluation of P450-mediated chemical activation. , 1998, Drug metabolism reviews.

[52]  C Masimirembwa,et al.  Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function. , 2000, Biochemical and biophysical research communications.

[53]  Stephen Ploch,et al.  Induction of hepatic aromatase by p,p′-DDE in adult male rats , 2001, Molecular and Cellular Endocrinology.

[54]  H. van de Waterbeemd,et al.  Can the Internet help to meet the challenges in ADME and e-ADME? , 2002, SAR and QSAR in environmental research.

[55]  C. Marcus,et al.  Quantitative Structure‐Activity Relationships in the Displacement of the Dihydrosafrole Metabolite‐Cytochrome P‐450 Complex , 1985 .

[56]  S. Wold,et al.  Partial Least Squares Projections to Latent Structures (PLS) in Chemistry , 2002 .

[57]  Johann Gasteiger,et al.  The Coding of the Three-Dimensional Structure of Molecules by Molecular Transforms and Its Application to Structure-Spectra Correlations and Studies of Biological Activity , 1996, J. Chem. Inf. Comput. Sci..

[58]  D. Parke,et al.  Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals. , 1998, Mutation research.

[59]  S. Ekins,et al.  Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. , 1999, Pharmacogenetics.

[60]  A. Cavalli,et al.  A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. , 2001, Journal of medicinal chemistry.

[61]  A. Hopfinger A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis , 1980 .

[62]  C. Ioannides,et al.  Quantitative structure–activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[63]  Alexander D. MacKerell Molecular Dynamics Simulation Analysis of a Sodium Dodecyl Sulfate Micelle in Aqueous Solution: Decreased Fluidity of the Micelle Hydrocarbon Interior , 1995 .

[64]  S H Unger,et al.  On model building in structure-activity relationships. A reexamination of adrenergic blocking activity of beta-halo-beta-arylalkylamines. , 1973, Journal of medicinal chemistry.

[65]  D A Smith,et al.  Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase). , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[66]  Zbigniew Michalewicz,et al.  Genetic Algorithms + Data Structures = Evolution Programs , 1992, Artificial Intelligence.

[67]  S. Ekins,et al.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[68]  Thomas A. Halgren,et al.  Merck molecular force field. IV. conformational energies and geometries for MMFF94 , 1996, J. Comput. Chem..

[69]  Antti Poso,et al.  A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors , 2001, J. Comput. Aided Mol. Des..

[70]  S. Ekins,et al.  Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates. , 1999, The Journal of pharmacology and experimental therapeutics.

[71]  C. Lemmen,et al.  FLEXS: a method for fast flexible ligand superposition. , 1998, Journal of medicinal chemistry.

[72]  Sean Ekins,et al.  Three‐Dimensional Quantitative Structure Activity Relationship for Cyp2d6 Substrates , 2002 .

[73]  F ROSENBLATT,et al.  The perceptron: a probabilistic model for information storage and organization in the brain. , 1958, Psychological review.

[74]  Sean Ekins,et al.  In vitro and pharmacophore insights into CYP3A enzymes. , 2003, Trends in pharmacological sciences.

[75]  Matthias Rarey,et al.  Small Molecule Docking and Scoring , 2001 .

[76]  J. Halpert,et al.  A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5* , 2003, The Journal of Biological Chemistry.

[77]  Jeffrey P. Jones,et al.  A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions. , 2000, Journal of medicinal chemistry.

[78]  A. Wood,et al.  Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test. , 1995, British journal of clinical pharmacology.

[79]  F. Guengerich,et al.  Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. , 1993, Journal of medicinal chemistry.

[80]  M. Karplus,et al.  Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. , 1996, Journal of medicinal chemistry.

[81]  A. Rettie,et al.  Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. , 1998, Biochemistry.

[82]  K. Korzekwa,et al.  Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. , 1994, Biochemistry.

[83]  Christian Lemmen,et al.  Computational methods for the structural alignment of molecules , 2000, J. Comput. Aided Mol. Des..

[84]  J. E. Schultz Biotransformation von Arzneimitteln, Band 3. Von S. Pfeifer. 560 S. Verlag Chemie, Weinheim, 1980. Lw. DM 118,— , 1980 .

[85]  J. Freidman,et al.  Multivariate adaptive regression splines , 1991 .

[86]  C Skoda,et al.  The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[87]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[88]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[89]  D. Lewis,et al.  Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[90]  D. F. Lewis,et al.  Application of process chemistry and SAR modelling to the evaluation of health findings of lower olefins. , 2001, Chemico-biological interactions.

[91]  A. Balaban Highly discriminating distance-based topological index , 1982 .

[92]  J B Houston,et al.  CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. , 1999, British journal of clinical pharmacology.

[93]  P. Labute,et al.  Binary Quantitative Structure—Activity Relationship (QSAR) Analysis of Estrogen Receptor Ligands. , 1999 .

[94]  Gilles Klopman,et al.  META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..

[95]  S. Chatterjee,et al.  Regression Analysis by Example , 1979 .

[96]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[97]  S A van Acker,et al.  A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.

[98]  S. Pickett,et al.  GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.

[99]  T. Wobbes,et al.  Comparative MO-QSAR studies in various species including man. , 1996, Chemico-biological interactions.

[100]  T. Halgren MMFF VI. MMFF94s option for energy minimization studies , 1999, J. Comput. Chem..

[101]  P A Kollman,et al.  Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: insights from docking, molecular dynamics, and quantum chemical calculations. , 2001, Journal of medicinal chemistry.

[102]  William L. Jorgensen,et al.  OPLS ALL-ATOM MODEL FOR AMINES : RESOLUTION OF THE AMINE HYDRATION PROBLEM , 1999 .

[103]  Gisbert Schneider,et al.  A fast virtual screening filter for cytochrome P450 3A4 inhibition liability of compound libraries , 2002 .

[104]  György M. Keserü,et al.  A virtual high throughput screen for high affinity cytochrome P450cam substrates. Implications for in silico prediction of drug metabolism , 2001, J. Comput. Aided Mol. Des..

[105]  György M Keseru,et al.  A neural network based virtual screening of cytochrome P450 3A4 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[106]  M J Sternberg,et al.  A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. , 1991, Carcinogenesis.

[107]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[108]  Asuka Nanbo,et al.  Mechanistic Study on N‐Demethylation Catalyzed with P450 by Quantitative Structure Activity Relationship using Electronic Properties of 4‐Substituted N,N‐Dimethylaniline , 2002 .

[109]  A. Leach Molecular Modelling: Principles and Applications , 1996 .

[110]  C. Ioannides,et al.  A quantitative structure-activity relationship study on a series of 10 para-substituted toluenes binding to cytochrome P4502B4 (CYP2B4), and their hydroxylation rates. , 1995, Biochemical pharmacology.

[111]  B D Silverman,et al.  Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. , 1996, Journal of medicinal chemistry.

[112]  D. Lewis,et al.  Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. , 2002, Toxicology.

[113]  Philip N. Judson,et al.  Representation of Chemical Structures in Knowledge‐Based Systems: The StAR System. , 1997 .

[114]  John Shorter,et al.  Linear Free Energy Relationships (LFER) , 2002 .

[115]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[116]  G. Crippen,et al.  Prediction of Physicochemical Parameters by Atomic Contributions. , 1999 .

[117]  D. Lewis,et al.  Molecular modelling and quantitative structure-activity relationship studies on the interaction of omeprazole with cytochrome P450 isozymes. , 1998, Toxicology.

[118]  Anton J. Hopfinger,et al.  Prediction of Ligand—Receptor Binding Free Energy by 4D‐QSAR Analysis: Application to a Set of Glucose Analogue Inhibitors of Glycogen Phosphorylase. , 2000 .

[119]  H. Wiener Structural determination of paraffin boiling points. , 1947, Journal of the American Chemical Society.

[120]  A. I. Archakov,et al.  Cytochrome P450 database for prediction of drugs' fate in living systems , 1995 .

[121]  Bernard F. Buxton,et al.  Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..

[122]  David F. V. Lewis,et al.  Molecular modeling of human cytochrome P450–substrate interactions , 2002, Drug metabolism reviews.

[123]  Gunnar Rätsch,et al.  An introduction to kernel-based learning algorithms , 2001, IEEE Trans. Neural Networks.

[124]  T Ishizaki,et al.  Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes. , 2003, British journal of clinical pharmacology.

[125]  F. Guengerich,et al.  Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. , 1985, Cancer research.

[126]  D. Lewis,et al.  Interaction of a series of nitriles with the alcohol-inducible isoform of P450: computer analysis of structure-activity relationships. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[127]  A. J. Hopfinger INHIBITION OF DIHYDROFOLATE REDUCTASE: STRUCTURE-ACTIVITY CORRELATIONS OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES BASED UPON MOLECULAR SHAPE ANALYSIS , 1981 .

[128]  W. Dunn,et al.  Principal components analysis and partial least squares regression , 1989 .

[129]  Ferran Sanz,et al.  THEORETICAL STUDY ON THE METABOLISM OF CAFFEINE BY CYTOCHROME P-450 1A2 AND ITS INHIBITION , 1994 .

[130]  Gabriele Cruciani,et al.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.

[131]  Gianpaolo Bravi,et al.  Application of MS‐WHIM Descriptors: 1. Introduction of New Molecular Surface Properties and 2. Prediction of Binding Affinity Data , 2000 .

[132]  M. Pastor,et al.  A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis. , 1997, Journal of medicinal chemistry.

[133]  Max Dobler,et al.  5D-QSAR: the key for simulating induced fit? , 2002, Journal of medicinal chemistry.

[134]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[135]  Kjeld Rasmussen,et al.  The Consistent Force Field. 5. PEF95SAC: Optimized potential energy function for alcohols and carbohydrates , 1997 .

[136]  N. Vermeulen,et al.  Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[137]  Tudor I. Oprea,et al.  Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors , 1996, J. Comput. Aided Mol. Des..

[138]  M Pastor,et al.  Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors. , 1997, Journal of medicinal chemistry.

[139]  B G Lake,et al.  Quantitative structure--activity relationships for inducers of cytochromes P450 and nuclear receptor ligands involved in P450 regulation within the CYP1, CYP2, CYP3 and CYP4 families. , 2002, Toxicology.

[140]  D. F. V. Lewis,et al.  Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor α (hERα) LBD: quantitative structure–activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[141]  Thomas A. Halgren Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94 , 1996, J. Comput. Chem..

[142]  Peter Willett,et al.  EVA: A Novel Theoretical Descriptor for QSAR Studies , 2002 .

[143]  J. Halpert,et al.  Structural basis of selective cytochrome P450 inhibition. , 1995, Annual review of pharmacology and toxicology.

[144]  M H Tarbit,et al.  Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[145]  Hua Gao,et al.  Application of BCUT Metrics and Genetic Algorithm in Binary QSAR Analysis , 2001, J. Chem. Inf. Comput. Sci..

[146]  Bryan F. J. Manly,et al.  Multivariate Statistical Methods : A Primer , 1986 .

[147]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[148]  John Fox,et al.  Using New Reasoning Technology in Chemical Information Systems , 1996, J. Chem. Inf. Comput. Sci..

[149]  A. Becke Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[150]  Jeffrey P. Jones,et al.  Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[151]  David F V Lewis,et al.  A quantitative structure-activity relationship (QSAR) study of mutagenicity in several series of organic chemicals likely to be activated by cytochrome P450 enzymes. , 2003, Teratogenesis, carcinogenesis, and mutagenesis.

[152]  T. Halgren MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular‐interaction energies and geometries , 1999, Journal of computational chemistry.

[153]  Johann Gasteiger,et al.  Superposition of Three-Dimensional Chemical Structures Allowing for Conformational Flexibility by a Hybrid Method , 1998, J. Chem. Inf. Comput. Sci..

[154]  C. Hansch,et al.  An analysis of the structure-activity relationship in the adrenergic blocking activity of the beta-haloalkylamines. , 1968, Biochemical pharmacology.

[155]  P. Maurel,et al.  Metabolism of the new immunosuppressor cyclosporin G by human liver cytochromes P450. , 1996, Biochemical pharmacology.

[156]  D. Lewis,et al.  On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism. , 2000, Biochemical pharmacology.

[157]  J. Venhorst,et al.  Design, synthesis, and characterization of 7-methoxy-4-(aminomethyl)coumarin as a novel and selective cytochrome P450 2D6 substrate suitable for high-throughput screening. , 1999, Chemical research in toxicology.

[158]  Ismael Zamora,et al.  Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates. , 2002, Methods in enzymology.

[159]  Subhash C. Basak Binding of barbiturates to cytochrome P450: A QSAR study using log P and topological indices , 1988 .

[160]  Ismael Zamora,et al.  Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors , 2002, J. Comput. Aided Mol. Des..

[161]  Serge Léger,et al.  Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. , 2002, Biochemistry.

[162]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[163]  R. Remmel,et al.  Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development. , 2002 .

[164]  Slobodan Petar Rendic,et al.  Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.

[165]  Alexander D. MacKerell,et al.  Molecular dynamics simulation of unsaturated lipid bilayers at low hydration: parameterization and comparison with diffraction studies. , 1997, Biophysical journal.

[166]  C. Levinthal How to fold graciously , 1969 .

[167]  J N Smith,et al.  The comparative metabolism of xenobiotics. , 1968, Advances in comparative physiology and biochemistry.

[168]  William L. Jorgensen,et al.  Development of an all-atom force field for heterocycles. Properties of liquid pyridine and diazenes , 1998 .

[169]  M Pastor,et al.  Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships. , 1997, Journal of medicinal chemistry.

[170]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[171]  M H Tarbit,et al.  Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[172]  C. Waller,et al.  Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[173]  A. Y. Lu,et al.  Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[174]  Gunnar Rätsch,et al.  Active Learning with Support Vector Machines in the Drug Discovery Process , 2003, J. Chem. Inf. Comput. Sci..

[175]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[176]  J D GRAHAM,et al.  STRUCTURE-ACTION RELATIONS IN N,N-DIMETHYL-2-HALO-GENOPHENETHYLAMINES. , 1963, Journal of medicinal chemistry.

[177]  N. Vermeulen,et al.  A refined substrate model for human cytochrome P450 2D6. , 1997, Chemical research in toxicology.

[178]  J. Halpert,et al.  Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity. , 2001, Biochemistry.

[179]  David E. Clark,et al.  Evolutionary Algorithms in Molecular Design , 1999 .

[180]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[181]  Gerhard Klebe,et al.  Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..

[182]  David Hartsough,et al.  Toward an Optimal Procedure for Variable Selection and QSAR Model Building , 2001, J. Chem. Inf. Comput. Sci..

[183]  R D Cramer,et al.  Three-dimensional structure-activity relationships. , 1988, Trends in pharmacological sciences.

[184]  Svante Wold,et al.  Partial least-squares method for spectrofluorimetric analysis of mixtures of humic acid and lignin sulfonate , 1983 .

[185]  G. Veith,et al.  A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. , 1996, Environmental health perspectives.

[186]  R. Wade,et al.  Prediction of drug binding affinities by comparative binding energy analysis. , 1997, Journal of medicinal chemistry.

[187]  Young-Sang Choi,et al.  Quantitative Structure-Activity Relationships (QSAR) Study of Flavonoid Derivatives for Inhibition of Cytochrome P450 1A2 , 2000 .

[188]  Ferran Sanz,et al.  3D-QSAR methods on the basis of ligand–receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands , 2000, J. Comput. Aided Mol. Des..

[189]  Sung Jin Cho,et al.  Rational Combinatorial Library Design. 1. Focus-2D: A New Approach to the Design of Targeted Combinatorial Chemical Libraries , 1998, J. Chem. Inf. Comput. Sci..

[190]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[191]  Johann Gasteiger,et al.  Multivariate structure‐activity relationships between data from a battery of biological tests and an ensemble of structure descriptors: The PLS method , 1984 .

[192]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[193]  Michel Petitjean,et al.  Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds , 1992, J. Chem. Inf. Comput. Sci..

[194]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[195]  J. Gasteiger,et al.  Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .

[196]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[197]  M. Waterman,et al.  Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points , 2001, The EMBO journal.

[198]  J. G. Snijders,et al.  Extension of a predictive substrate model for human cytochrome P4502D6. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[199]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[200]  D. Mansuy,et al.  The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling. , 1995, Biochemistry.

[201]  Péter Fábián,et al.  The directory of P450-containing systems in 1996 , 1997, Nucleic Acids Res..

[202]  M Pastor,et al.  Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design. , 1998, Journal of medicinal chemistry.

[203]  C. Yoon,et al.  Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids. , 1998, Biochemical pharmacology.

[204]  Maurice Dickins,et al.  Substrate SARs in human P450s. , 2002, Drug discovery today.

[205]  William L. Jorgensen,et al.  Development of an All-Atom Force Field for Heterocycles. Properties of Liquid Pyrrole, Furan, Diazoles, and Oxazoles , 1998 .

[206]  E Baston,et al.  Synthesis, evaluation and QSAR studies of highly potent aromatase inhibitors of the piperidinedione type. , 2001, Anti-cancer drug design.

[207]  G. Miller,et al.  Elucidation of distinct ligand binding sites for cytochrome P450 3A4. , 2000, Biochemistry.

[208]  A. Alex,et al.  Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.

[209]  J. Devillers Genetic algorithms in molecular modeling , 1996 .

[210]  A. Alex,et al.  A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.

[211]  C L Brooks,et al.  Do active site conformations of small ligands correspond to low free-energy solution structures? , 1998, Journal of computer-aided molecular design.

[212]  D. Mansuy,et al.  Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. , 1996, Biochemistry.

[213]  T. Halgren Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[214]  P N Judson,et al.  Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.

[215]  Jürgen Bajorath,et al.  Distinguishing between Natural Products and Synthetic Molecules by Descriptor Shannon Entropy Analysis and Binary QSAR Calculations , 2000, J. Chem. Inf. Comput. Sci..

[216]  Jeffrey P. Jones,et al.  Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. , 1999, Archives of biochemistry and biophysics.

[217]  M H Tarbit,et al.  Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives. , 1999, Journal of enzyme inhibition.

[218]  D. Nelson,et al.  Mining databases for cytochrome P450 genes. , 2002, Methods in enzymology.

[219]  Min Zhang,et al.  Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi. , 2003, Journal of medicinal chemistry.

[220]  Johann Gasteiger,et al.  Neural networks in chemistry and drug design , 1999 .

[221]  T. Halgren,et al.  Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules , 1996 .

[222]  Thomas A. Halgren,et al.  Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular. interactions , 1996, J. Comput. Chem..

[223]  D. Ferguson,et al.  A new approach to probing conformational space with molecular mechanics: Random incremental pulse search , 1989 .

[224]  Simon K. Kearsley,et al.  An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap , 1990 .

[225]  G T Tucker,et al.  Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6. , 2001, The Biochemical journal.

[226]  Nello Cristianini,et al.  An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .

[227]  I. Pajeva,et al.  Quantitative structure-activity relationship (QSAR) and three-dimensional QSAR analysis of a series of xanthates as inhibitors and inactivators of cytochrome P450 2B1 , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[228]  A. Cammarata,et al.  Interrelationship of the regression models used for structure-activity analyses. , 1972, Journal of medicinal chemistry.

[229]  David F. V. Lewis,et al.  Structure–activity relationship for human cytochrome P450 substrates and inhibitors , 2002, Drug metabolism reviews.

[230]  A. Cavalli,et al.  Comparative molecular field analysis of non-steroidal aromatase inhibitors: an extended model for two different structural classes. , 1998, Bioorganic & medicinal chemistry.

[231]  G Schneider,et al.  Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.

[232]  Johann Gasteiger,et al.  Electronegativity equalization: application and parametrization , 1985 .

[233]  J. Miners,et al.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. , 1998, British journal of clinical pharmacology.

[234]  S. Ekins,et al.  Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6. , 1999, The Journal of pharmacology and experimental therapeutics.

[235]  György M. Keserü,et al.  METAPRINT: A Metabolic Fingerprint. Application to Cassette Design for High-Throughput ADME Screening , 2002, J. Chem. Inf. Comput. Sci..

[236]  William L. Jorgensen,et al.  A comprehensive study of the rotational energy profiles of organic systems by ab initio MO theory, forming a basis for peptide torsional parameters , 1995, J. Comput. Chem..

[237]  Jure Zupan,et al.  NEURONALE NETZE IN DER CHEMIE , 1993 .

[238]  Bernard Testa,et al.  Drug Metabolism: Chemical and Biochemical Aspects , 1976 .

[239]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[240]  F. Darvas,et al.  Predicting metabolic pathways by logic programming , 1988 .

[241]  Tommy B Andersson,et al.  Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. , 2002, The Journal of pharmacology and experimental therapeutics.

[242]  Ramon Carbó-Dorca,et al.  Molecular Quantum Similarity-Based QSARs for Binding Affinities of Several Steroid Sets , 2002, J. Chem. Inf. Comput. Sci..

[243]  W. R. Wadt,et al.  Ab initio effective core potentials for molecular calculations. Potentials for main group elements Na to Bi , 1985 .

[244]  S. D. Turner,et al.  Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[245]  W. R. Wadt,et al.  Ab initio effective core potentials for molecular calculations , 1984 .

[246]  L. Benet,et al.  The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics , 1996, Clinical pharmacology and therapeutics.

[247]  A. Leach A Survey of Methods for Searching the Conformational Space of Small and Medium‐Sized Molecules , 1992 .

[248]  M H Tarbit,et al.  Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[249]  S. Ekins,et al.  Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors. , 1999, The Journal of pharmacology and experimental therapeutics.

[250]  M Karplus,et al.  Zinc binding in proteins and solution: A simple but accurate nonbonded representation , 1995, Proteins.

[251]  Shen Wang,et al.  Construction of a Virtual High Throughput Screen by 4D-QSAR Analysis: Application to a Combinatorial Library of Glucose Inhibitors of Glycogen Phosphorylase b , 1999, J. Chem. Inf. Comput. Sci..

[252]  S. Ekins,et al.  Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[253]  J. Halpert,et al.  Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450. , 1997, Life sciences.